COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study. Issue 10 (22nd October 2022)

Record Type:: Journal Article
Title:: COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study. Issue 10 (22nd October 2022)
Main Title:: COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study
Authors:: Niemann, Carsten U.
Awan, Farrukh T.
Fogliatto, Laura
Nikitin, Eugene
Samoilova, Olga
Habib, Adel
Foroutanpour, Kayhan
Kuptsova-Clarkson, Nataliya
Opat, Stephen
Abstract:
Is Part Of:: HemaSphere. Volume 6:Issue 10(2022)
Journal:: HemaSphere
Issue:: Volume 6:Issue 10(2022)
Issue Display:: Volume 6, Issue 10 (2022)
Year:: 2022
Volume:: 6
Issue:: 10
Issue Sort Value:: 2022-0006-0010-0000
Page Start:: e780
Page End:
Publication Date:: 2022-10-22
Subjects:: Hematology -- Periodicals
616.15005
Journal URLs:: https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/HS9.0000000000000780 ↗
Languages:: English
ISSNs:: 2572-9241
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 25960.xml